Would AbbVie’s top execs really pull the trigger on a $30B M&A deal? Why, yes, actually
Leave it to Jami Rubin to put the Big Pharma CEO on the spot.
On Friday’s call with the top team at AbbVie, the salty Goldman Sachs analyst asked AbbVie CEO Rick Gonzalez point blank about an earlier comment that he had made about his willingness to do a $20 billion to $30 billion M&A deal.
What followed was a good deal of bobbing and weaving, with caveats and qualifications aplenty. But Gonzalez also made it clear that if the right blockbuster came along, he would pull the trigger on a big acquisition.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
